Skip to main content

Peer Review reports

From: Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights

Original Submission
1 Jul 2022 Submitted Original manuscript
25 Aug 2022 Reviewed Reviewer Report - Kengo Nagashima
7 Sep 2022 Reviewed Reviewer Report - Frank Miller
7 Oct 2022 Author responded Author comments - Josep Ramon Marsal
Resubmission - Version 2
7 Oct 2022 Submitted Manuscript version 2
25 Oct 2022 Reviewed Reviewer Report - Kengo Nagashima
3 Nov 2022 Reviewed Reviewer Report - Frank Miller
8 Nov 2022 Author responded Author comments - Josep Ramon Marsal
Resubmission - Version 3
8 Nov 2022 Submitted Manuscript version 3
23 Nov 2022 Reviewed Reviewer Report - Kengo Nagashima
1 Dec 2022 Reviewed Reviewer Report - Frank Miller
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Dec 2022 Editorially accepted
21 Dec 2022 Article published 10.1186/s13063-022-06977-4

You can find further information about peer review here.

Back to article page